RoslinCT developing life-changing gene and cell therapies in Edinburgh’s BioQuarter-Company has doubled its workforce in the last year and plans 25% more jobs by end of 2021
A new state-of-the-art cell and gene therapy manufacturing facility in Edinburgh has been formally opened by Ian McCubbin CBE on behalf of Sir Patrick Vallance, the Chief Scientific Adviser to the UK government.
The building – which is called the BioCube – is an additional home to RoslinCT, one of the world’s leading manufacturers of human cell and gene therapies, which works with clients to develop and manufacture life-…
Babraham, 07 October 2021: Babraham Research Campus Ltd, which develops and manages the Babraham Research Campus, and the Babraham Institute have secured funding for fifteen PhD studentships from UKRI-BBSRCas part of a Collaborative Training Partnership (CTP). Through a tailored programme of skills training and scientific and industry supervision the partnership will produce a cohort of bioscience researchers equipped with excellent research skills and commercial know-how. Campus CTP projects combine scientific and industry supervision to train PhD students…
AMSBIO have supplied custom Chimeric antigen receptor (CAR)-T products to the University of Strathclyde (UoS) in Glasgow, UK, and ScreenIn3D Ltd, allowing them to perform novel immune-oncology assays in 3D microfluidic cancer models.CAR-T cells are genetically modified T-cells used to find and kill cancer cells by targeting specific cancer-associated proteins, or antigens. CAR-T cell therapy is highly effective against haematological malignancies, but faces challenges in solid tumours due to the immunosuppressive effects of the tumour microenvironment. Often, combination therapies, such…
Marcel Kuiper has recently joined CPI as a Business Development Manager - Outreach. Marcel joins CPI from KTN where he was a Knowledge Transfer Manager in the Health Team.
He is based in Cambridgeshire in order to engage SMEs in the Cambridge and Peterborough Combined Authority (CPCA) Region which could benefit from a new ERDF Project, SPRINT (Supporting Process Innovation for Novel Therapies). SPRINT aims to support and accelerate the commercialisation of novel biological therapeutics as well as equipment and processes supporting these therapies.
Please contact Marcel (marcel.kuiper@uk-cpi.…
Cambridge, UK, 05 October 2021: CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single- and multi-organ microphysiological systems (MPS), today announced the commercial launch of its Oncology Service in response to the global need to improve cancer drug discovery approval rates.
Understanding the relationship between pharmacokinetics, pharmacodynamics (PK/PD) and efficacy is critical to the successful development of new medicines, but at present this relationship is primarily investigated using animal models – a process that is time-consuming, ethically…
Cambridge, UK, 05 October 2021: Mogrify Limited (Mogrify®), a biopharmaceutical company pioneering the development of a new class of in vivo reprogramming therapies and transforming the development of ex vivo cell therapies, today announced the appointment of Dr. Louise Modis as Chief Scientific Officer, following the recent completion of a $33 million USD Series A funding. Louise is an accomplished scientific leader in therapeutic discovery and development, and holds considerable experience in the progression of pre-clinical and clinical-stage assets, across various modalities and…
Today marks the launch of Patent Enforcement in the UK and Trans-Pacific Countries, an essential guide for private practitioners, in-house lawyers and other professionals with responsibility for intellectual property who are interested in the Trans-Pacific region.
Published by Globe Law and Business, the guide features contributions by Taylor Wessing experts Paul England, Amanda Ebbutt and Tom Foster, as well as a number of leading patent lawyers from Australia, Canada, US, Japan, South Korea, Singapore and New Zealand.
Paul England, senior professional support lawyer and the guide's…
We have helped secure the sale of the private healthcare company behind London's Parkside and Highgate hospitals.
The deal saw Aspen Healthcare, which runs eight hospitals and clinics around the UK, sold to NorthWest Healthcare Properties Real Estate Investment Trust.
The Canadian-based healthcare property trust took over in August this year, but it already owned some of the sites leased by Aspen Healthcare.
Our team worked with specialist insurance broker Howdens to help arrange a "synthetic" warranty and indemnity, and tax deed insurance package for the buyer.
This is one of…
New research reveals the confidence and capability of business in addressing international trade concerns.
In-Brief:
What are trade teams being asked to support and how confident do they feel in meeting business needs?
To deliver long-term value, what practical steps are needed to move from just the ‘basics’ to best in class?
How do UK companies differ from their global peers and how do they define their trade strategy?